Cargando…
Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis
BACKGROUND: Maintenance therapy with targeted agents for prolonging remission for ovarian cancer patients remains controversial. As a result, a meta-analysis was conducted to assess the effectiveness and safety of using maintenance therapy with targeted agents for the treatment of ovarian cancer. ME...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581706/ https://www.ncbi.nlm.nih.gov/pubmed/26402447 http://dx.doi.org/10.1371/journal.pone.0139026 |
_version_ | 1782391604558954496 |
---|---|
author | Qian, Xinyu Qin, Jing Pan, Songdan Li, Xin Pan, Yuelong Ma, Shenglin |
author_facet | Qian, Xinyu Qin, Jing Pan, Songdan Li, Xin Pan, Yuelong Ma, Shenglin |
author_sort | Qian, Xinyu |
collection | PubMed |
description | BACKGROUND: Maintenance therapy with targeted agents for prolonging remission for ovarian cancer patients remains controversial. As a result, a meta-analysis was conducted to assess the effectiveness and safety of using maintenance therapy with targeted agents for the treatment of ovarian cancer. METHODS: From inception to January 2015, we searched for randomized, controlled trials (RCTs) using the following databases: PubMed, ScienceDirect, the Cochrane Library, Clinicaltrials.gov and EBSCO. Eligible trials included RCTs that evaluated standard chemotherapy which was either followed or not followed by targeted maintenance in patients with ovarian cancer who had been previously receiving adjunctive treatments, such as cytoreductive surgery and standard chemotherapy. The outcome measures included progression-free survival (PFS), overall survival (OS) and incidence of adverse events. RESULTS: A total of 13 RCTs, which were published between 2006 and 2014, were found to be in accordance with our inclusion criteria. The primary meta-analysis indicated that both PFS and OS were statistically and significantly improved in the targeted maintenance therapy group as compared to the control group (PFS: HR = 0.84, 95%CI: 0.75 to 0.95, p = 0.001; OS: HR = 0.91, 95%CI: 0.84 to 0.98, p = 0.02). When taking safety into consideration, the use of targeted agents was significantly correlated with increased risks of fatigue, diarrhea, nausea, vomiting, and hypertension. However, no significant differences were found in incidence rates of abdominal pain, constipation or joint pain. CONCLUSIONS: Our results indicate that targeted maintenance therapy clearly improves the survival of ovarian cancer patients but may also increase the incidence of adverse events. Additional randomized, double-blind, placebo-controlled, multicenter investigations will be required on a larger cohort of patients to verify our findings. |
format | Online Article Text |
id | pubmed-4581706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45817062015-10-01 Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis Qian, Xinyu Qin, Jing Pan, Songdan Li, Xin Pan, Yuelong Ma, Shenglin PLoS One Research Article BACKGROUND: Maintenance therapy with targeted agents for prolonging remission for ovarian cancer patients remains controversial. As a result, a meta-analysis was conducted to assess the effectiveness and safety of using maintenance therapy with targeted agents for the treatment of ovarian cancer. METHODS: From inception to January 2015, we searched for randomized, controlled trials (RCTs) using the following databases: PubMed, ScienceDirect, the Cochrane Library, Clinicaltrials.gov and EBSCO. Eligible trials included RCTs that evaluated standard chemotherapy which was either followed or not followed by targeted maintenance in patients with ovarian cancer who had been previously receiving adjunctive treatments, such as cytoreductive surgery and standard chemotherapy. The outcome measures included progression-free survival (PFS), overall survival (OS) and incidence of adverse events. RESULTS: A total of 13 RCTs, which were published between 2006 and 2014, were found to be in accordance with our inclusion criteria. The primary meta-analysis indicated that both PFS and OS were statistically and significantly improved in the targeted maintenance therapy group as compared to the control group (PFS: HR = 0.84, 95%CI: 0.75 to 0.95, p = 0.001; OS: HR = 0.91, 95%CI: 0.84 to 0.98, p = 0.02). When taking safety into consideration, the use of targeted agents was significantly correlated with increased risks of fatigue, diarrhea, nausea, vomiting, and hypertension. However, no significant differences were found in incidence rates of abdominal pain, constipation or joint pain. CONCLUSIONS: Our results indicate that targeted maintenance therapy clearly improves the survival of ovarian cancer patients but may also increase the incidence of adverse events. Additional randomized, double-blind, placebo-controlled, multicenter investigations will be required on a larger cohort of patients to verify our findings. Public Library of Science 2015-09-24 /pmc/articles/PMC4581706/ /pubmed/26402447 http://dx.doi.org/10.1371/journal.pone.0139026 Text en © 2015 Qian et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Qian, Xinyu Qin, Jing Pan, Songdan Li, Xin Pan, Yuelong Ma, Shenglin Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis |
title | Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis |
title_full | Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis |
title_fullStr | Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis |
title_short | Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis |
title_sort | maintenance therapy in ovarian cancer with targeted agents improves pfs and os: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581706/ https://www.ncbi.nlm.nih.gov/pubmed/26402447 http://dx.doi.org/10.1371/journal.pone.0139026 |
work_keys_str_mv | AT qianxinyu maintenancetherapyinovariancancerwithtargetedagentsimprovespfsandosasystematicreviewandmetaanalysis AT qinjing maintenancetherapyinovariancancerwithtargetedagentsimprovespfsandosasystematicreviewandmetaanalysis AT pansongdan maintenancetherapyinovariancancerwithtargetedagentsimprovespfsandosasystematicreviewandmetaanalysis AT lixin maintenancetherapyinovariancancerwithtargetedagentsimprovespfsandosasystematicreviewandmetaanalysis AT panyuelong maintenancetherapyinovariancancerwithtargetedagentsimprovespfsandosasystematicreviewandmetaanalysis AT mashenglin maintenancetherapyinovariancancerwithtargetedagentsimprovespfsandosasystematicreviewandmetaanalysis |